These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 36997873)
1. Impact of non-pharmaceutical interventions, weather, vaccination, and variants on COVID-19 transmission across departments in France. Paireau J; Charpignon ML; Larrieu S; Calba C; Hozé N; Boëlle PY; Thiebaut R; Prague M; Cauchemez S BMC Infect Dis; 2023 Mar; 23(1):190. PubMed ID: 36997873 [TBL] [Abstract][Full Text] [Related]
2. Non-pharmaceutical interventions, vaccination, and the SARS-CoV-2 delta variant in England: a mathematical modelling study. Sonabend R; Whittles LK; Imai N; Perez-Guzman PN; Knock ES; Rawson T; Gaythorpe KAM; Djaafara BA; Hinsley W; FitzJohn RG; Lees JA; Kanapram DT; Volz EM; Ghani AC; Ferguson NM; Baguelin M; Cori A Lancet; 2021 Nov; 398(10313):1825-1835. PubMed ID: 34717829 [TBL] [Abstract][Full Text] [Related]
3. Using a population-based Kalman estimator to model the COVID-19 epidemic in France: estimating associations between disease transmission and non-pharmaceutical interventions. Collin A; Hejblum BP; Vignals C; Lehot L; Thiébaut R; Moireau P; Prague M Int J Biostat; 2024 May; 20(1):13-41. PubMed ID: 36607837 [TBL] [Abstract][Full Text] [Related]
4. The temporal association of introducing and lifting non-pharmaceutical interventions with the time-varying reproduction number (R) of SARS-CoV-2: a modelling study across 131 countries. Li Y; Campbell H; Kulkarni D; Harpur A; Nundy M; Wang X; Nair H; Lancet Infect Dis; 2021 Feb; 21(2):193-202. PubMed ID: 33729915 [TBL] [Abstract][Full Text] [Related]
5. Estimating the population effectiveness of interventions against COVID-19 in France: A modelling study. Ganser I; Buckeridge DL; Heffernan J; Prague M; Thiébaut R Epidemics; 2024 Mar; 46():100744. PubMed ID: 38324970 [TBL] [Abstract][Full Text] [Related]
6. Untangling the changing impact of non-pharmaceutical interventions and vaccination on European COVID-19 trajectories. Ge Y; Zhang WB; Wu X; Ruktanonchai CW; Liu H; Wang J; Song Y; Liu M; Yan W; Yang J; Cleary E; Qader SH; Atuhaire F; Ruktanonchai NW; Tatem AJ; Lai S Nat Commun; 2022 Jun; 13(1):3106. PubMed ID: 35661759 [TBL] [Abstract][Full Text] [Related]
7. The impact of spatial connectivity on NPIs effectiveness. Sabbatini CE; Pullano G; Di Domenico L; Rubrichi S; Bansal S; Colizza V BMC Infect Dis; 2024 Jan; 24(1):21. PubMed ID: 38166649 [TBL] [Abstract][Full Text] [Related]
8. The impact of non-pharmaceutical interventions on SARS-CoV-2 transmission across 130 countries and territories. Liu Y; Morgenstern C; Kelly J; Lowe R; ; Jit M BMC Med; 2021 Feb; 19(1):40. PubMed ID: 33541353 [TBL] [Abstract][Full Text] [Related]
9. Association of Simulated COVID-19 Vaccination and Nonpharmaceutical Interventions With Infections, Hospitalizations, and Mortality. Patel MD; Rosenstrom E; Ivy JS; Mayorga ME; Keskinocak P; Boyce RM; Hassmiller Lich K; Smith RL; Johnson KT; Delamater PL; Swann JL JAMA Netw Open; 2021 Jun; 4(6):e2110782. PubMed ID: 34061203 [TBL] [Abstract][Full Text] [Related]
10. Lifting non-pharmaceutical interventions following the COVID-19 pandemic - the quiet before the storm? Oh KB; Doherty TM; Vetter V; Bonanni P Expert Rev Vaccines; 2022 Nov; 21(11):1541-1553. PubMed ID: 36039786 [TBL] [Abstract][Full Text] [Related]
11. Impact of vaccination and non-pharmaceutical interventions on SARS-CoV-2 dynamics in Switzerland. Shattock AJ; Le Rutte EA; Dünner RP; Sen S; Kelly SL; Chitnis N; Penny MA Epidemics; 2022 Mar; 38():100535. PubMed ID: 34923396 [TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 transmission in opposition-controlled Northwest Syria: modeling pandemic responses during political conflict. Marzouk M; Alhiraki OA; Aguas R; Gao B; Clapham H; Obaid W; Altaleb H; Almhawish N; Rihawi H; Abbara A; Douedari Y; Hariri M; Howard N; Int J Infect Dis; 2022 Apr; 117():103-115. PubMed ID: 35123027 [TBL] [Abstract][Full Text] [Related]
13. Factors Associated with the Implementation of Non-Pharmaceutical Interventions for Reducing Coronavirus Disease 2019 (COVID-19): A Systematic Review. Regmi K; Lwin CM Int J Environ Res Public Health; 2021 Apr; 18(8):. PubMed ID: 33920613 [TBL] [Abstract][Full Text] [Related]
14. Vaccination and non-pharmaceutical interventions for COVID-19: a mathematical modelling study. Moore S; Hill EM; Tildesley MJ; Dyson L; Keeling MJ Lancet Infect Dis; 2021 Jun; 21(6):793-802. PubMed ID: 33743847 [TBL] [Abstract][Full Text] [Related]
15. Cold and dry winter conditions are associated with greater SARS-CoV-2 transmission at regional level in western countries during the first epidemic wave. Landier J; Paireau J; Rebaudet S; Legendre E; Lehot L; Fontanet A; Cauchemez S; Gaudart J Sci Rep; 2021 Jun; 11(1):12756. PubMed ID: 34140557 [TBL] [Abstract][Full Text] [Related]
16. Inferring the effective start dates of non-pharmaceutical interventions during COVID-19 outbreaks. Kohanovski I; Obolski U; Ram Y Int J Infect Dis; 2022 Apr; 117():361-368. PubMed ID: 34986406 [TBL] [Abstract][Full Text] [Related]
17. Impact of non-pharmaceutical interventions and vaccination on COVID-19 outbreaks in Nunavut, Canada: a Canadian Immunization Research Network (CIRN) study. Vilches TN; Abdollahi E; Cipriano LE; Haworth-Brockman M; Keynan Y; Sheffield H; Langley JM; Moghadas SM BMC Public Health; 2022 May; 22(1):1042. PubMed ID: 35614429 [TBL] [Abstract][Full Text] [Related]
18. Vaccination as an alternative to non-drug interventions to prevent local resurgence of COVID-19. Pan J; Zhu W; Tian J; Liu Z; Xu A; Yao Y; Wang W Infect Dis Poverty; 2022 Mar; 11(1):36. PubMed ID: 35346382 [TBL] [Abstract][Full Text] [Related]
19. Dynamic Panel Data Modeling and Surveillance of COVID-19 in Metropolitan Areas in the United States: Longitudinal Trend Analysis. Oehmke TB; Post LA; Moss CB; Issa TZ; Boctor MJ; Welch SB; Oehmke JF J Med Internet Res; 2021 Feb; 23(2):e26081. PubMed ID: 33481757 [TBL] [Abstract][Full Text] [Related]
20. Assessing the impact of non-pharmaceutical interventions (NPIs) and BCG vaccine cross-protection in the transmission dynamics of SARS-CoV-2 in eastern Africa. Kilonzo CM; Wamalwa M; Whegang SY; Tonnang HEZ BMC Res Notes; 2022 Sep; 15(1):283. PubMed ID: 36059028 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]